Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Virtus Biotech ETF BBP

Full chart Compare

Set alert

105.02 USD +1.50 (+1.45%)

Nov 4, 2026, 2:35 PM EST

103.39 Day range 105.72

73.55 52-week range 110.05

YTD: +31.40%
1 year: +43.86%

Issuer: Virtus
Asset class: Sector Equity
Expense ratio: 0.34%
Assets under management: $133.93M
NAV: 103.02
Holdings: 198
Inception: 2014-12-16
Top 10 weight: 26.96%

MRNA Moderna Inc 5.86%
VSTM Verastem Inc 3.10%
OMER Omeros Corp 2.70%
IOVA Iovance Biotherapeutics Inc 2.60%
HALO Halozyme Therapeutics Inc 2.46%
KNSA Kiniksa Pharmaceuticals International Plc 2.32%
REGN Regeneron Pharmaceuticals Inc 2.08%
RIGL Rigel Pharmaceuticals Inc 2.04%
XERS Xeris Biopharma Holdings Inc 1.98%
BGNE BeOne Medicines Ltd 1.81%
GILD Gilead Sciences Inc 1.80%
ADMA ADMA Biologics Inc 1.78%
EXEL Exelixis Inc 1.75%
AMGN Amgen Inc 1.74%
ARQT Arcutis Biotherapeutics Inc 1.70%
PTGX Protagonist Therapeutics Inc 1.68%
ZLAB Zai Lab Ltd 1.68%
ZYME Zymeworks Inc 1.68%
BIIB Biogen Inc 1.65%
VRTX Vertex Pharmaceuticals Inc 1.65%
TGTX TG Therapeutics Inc 1.60%
LGND Ligand Pharmaceuticals Inc 1.59%
SRPT Sarepta Therapeutics Inc 1.59%
ROIV Roivant Sciences Ltd 1.58%
TARS Tarsus Pharmaceuticals Inc 1.57%

Healthcare 100.00%

United States 95.32%
China 1.68%
United Kingdom 1.60%
Switzerland 1.40%

Updated 2026-11-04